Literature DB >> 19523907

Structural basis for DNase activity of a conserved protein implicated in CRISPR-mediated genome defense.

Blake Wiedenheft1, Kaihong Zhou, Martin Jinek, Scott M Coyle, Wendy Ma, Jennifer A Doudna.   

Abstract

Acquired immunity in prokaryotes is achieved by integrating short fragments of foreign nucleic acids into clustered regularly interspaced short palindromic repeats (CRISPRs). This nucleic acid-based immune system is mediated by a variable cassette of up to 45 protein families that represent distinct immune system subtypes. CRISPR-associated gene 1 (cas1) encodes the only universally conserved protein component of CRISPR immune systems, yet its function is unknown. Here we show that the Cas1 protein is a metal-dependent DNA-specific endonuclease that produces double-stranded DNA fragments of approximately 80 base pairs in length. The 2.2 A crystal structure of the Cas1 protein reveals a distinct fold and a conserved divalent metal ion-binding site. Mutation of metal ion-binding residues, chelation of metal ions, or metal-ion substitution inhibits Cas1-catalyzed DNA degradation. These results provide a foundation for understanding how Cas1 contributes to CRISPR function, perhaps as part of the machinery for processing foreign nucleic acids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523907     DOI: 10.1016/j.str.2009.03.019

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  100 in total

1.  Characterization of the CRISPR/Cas subtype I-A system of the hyperthermophilic crenarchaeon Thermoproteus tenax.

Authors:  André Plagens; Britta Tjaden; Anna Hagemann; Lennart Randau; Reinhard Hensel
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

2.  Nature and intensity of selection pressure on CRISPR-associated genes.

Authors:  Nobuto Takeuchi; Yuri I Wolf; Kira S Makarova; Eugene V Koonin
Journal:  J Bacteriol       Date:  2011-12-16       Impact factor: 3.490

Review 3.  RNA-guided genetic silencing systems in bacteria and archaea.

Authors:  Blake Wiedenheft; Samuel H Sternberg; Jennifer A Doudna
Journal:  Nature       Date:  2012-02-15       Impact factor: 49.962

Review 4.  CRISPR-Cas adaptation: insights into the mechanism of action.

Authors:  Gil Amitai; Rotem Sorek
Journal:  Nat Rev Microbiol       Date:  2016-01-11       Impact factor: 60.633

5.  Purification, crystallization, crystallographic analysis and phasing of the CRISPR-associated protein Csm2 from Thermotoga maritima.

Authors:  Gloria Gallo; Gilles Augusto; Giulliana Rangel; André Zelanis; Marcelo A Mori; Cláudia Barbosa Campos; Martin Würtele
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-09-23       Impact factor: 1.056

6.  The structure of the CRISPR-associated protein Csa3 provides insight into the regulation of the CRISPR/Cas system.

Authors:  Nathanael G Lintner; Kenneth A Frankel; Susan E Tsutakawa; Donald L Alsbury; Valérie Copié; Mark J Young; John A Tainer; C Martin Lawrence
Journal:  J Mol Biol       Date:  2010-11-18       Impact factor: 5.469

7.  Structures of the CRISPR genome integration complex.

Authors:  Addison V Wright; Jun-Jie Liu; Gavin J Knott; Kevin W Doxzen; Eva Nogales; Jennifer A Doudna
Journal:  Science       Date:  2017-07-20       Impact factor: 47.728

8.  Role of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology.

Authors:  M A Serbanescu; M Cordova; K Krastel; R Flick; N Beloglazova; A Latos; A F Yakunin; D B Senadheera; D G Cvitkovitch
Journal:  J Bacteriol       Date:  2014-12-08       Impact factor: 3.490

Review 9.  Evolution of adaptive immunity from transposable elements combined with innate immune systems.

Authors:  Eugene V Koonin; Mart Krupovic
Journal:  Nat Rev Genet       Date:  2014-12-09       Impact factor: 53.242

Review 10.  Adapting to new threats: the generation of memory by CRISPR-Cas immune systems.

Authors:  Robert Heler; Luciano A Marraffini; David Bikard
Journal:  Mol Microbiol       Date:  2014-06-04       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.